bsdmedical8k.htm


UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  May 16, 2012
 
BSD MEDICAL CORPORATION
 
(Exact name of registrant as specified in its charter)
 
Delaware
0-10783
75-1590407
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

2188 West 2200 South
 
Salt Lake City, Utah 84119
 
(Address of principal executive offices, including Zip Code)
 
Registrant’s telephone number, including area code:  (801) 972-5555
 
N/A
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

--
 
 

 

Item 7.01 Regulation FD Disclosure.
 
On May 16, 2012, BSD Medical Corporation issued a press release announcing a live investor conference call and webcast scheduled for Thursday, May 24, 2012 at 2:00 p.m. Eastern time/12:00 p.m. Mountain time.

A copy of the press release is furnished herewith as Exhibit 99.1.


Item 9.01  Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit No.
 
Description
99.1
 
Press release dated May 16, 2012 announcing investor conference call

 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BSD MEDICAL CORPORATION
 
Date:  May 16, 2012
   
 
By:  /s/ Dennis P. Gauger
 
 
Name:  Dennis P. Gauger
 
 
Title:    Chief Financial Officer
 

 
 
 

 

EXHIBIT INDEX
 
Exhibit No.
 
Description
99.1
 
Press release dated May 16, 2012 announcing investor conference call